scholarly journals Evaluating the quality of asynchronously- versus synchronously-delivered virtual care: Differences in rates of reported medication side effects among patients with erectile dysfunction on a direct-to-consumer telehealth platform (Preprint)

10.2196/32126 ◽  
2021 ◽  
Author(s):  
Lauren Broffman ◽  
Melynda Barnes ◽  
Kevin Stern ◽  
Amy Westergren
Keyword(s):  
Erectile Dysfunction ◽  
Side Effects ◽  
Direct To Consumer ◽  
Medication Side Effects ◽  
Virtual Care ◽  
Medication Side

Challenging Symptoms

2017 ◽  
Author(s):  
Barton T. Bobb ◽  
Devon Fletcher
Keyword(s):  
Quality Of Life ◽  
Palliative Care ◽  
Side Effects ◽  
Sleep Disorders ◽  
Assessment Tools ◽  
Dry Mouth ◽  
Advanced Practice ◽  
Medication Side Effects ◽  
Medication Side

Dry mouth, hiccups, fevers, pruritus, and sleep disorders are symptoms often found in palliative care patients. These symptoms can be challenging to treat, and they require that the advanced practice registered nurse (APRN) has a working knowledge of the causative conditions in order to effectively manage the symptoms. Appropriate assessment tools for these common symptoms are reviewed, as are their various causes, from medication side effects, systemic illness, and physical and psychological causes. Pharmacological, nonpharmacological, and interventional treatments are offered, with the caveat that all interventions must be individualized to the patient’s care goals and with quality of life in mind.

Evaluating the quality of asynchronously versus synchronously delivered virtual care: Differences in rates of reported medication side effects by patients on a direct-to-consumer telehealth platform (Preprint)

2021 ◽  
Author(s):  
Lauren Broffman ◽  
Melynda Barnes ◽  
Kevin Stern ◽  
Amy Westergren
Keyword(s):  
Health Care ◽  
Side Effects ◽  
Policy Makers ◽  
Direct To Consumer ◽  
Virtual Care ◽  
Patient Reported ◽  
Medication Side ◽  
Health Care Encounters ◽  
Established Relationship ◽  
End To End

BACKGROUND End-to-end asynchronous health care encounters are becoming an increasingly mainstream form of telehealth. Unlike synchronous telehealth, policy makers and other key health care stakeholders have been hesitant to fully embrace the fully asynchronous modality, especially in the context of direct-to-consumer (DTC) platforms where encounters are patient-initiated and there is no pre-established relationship with their provider. This hesitation is compounded by limited research comparing outcomes between asynchronous and synchronous care, especially in the DTC context. OBJECTIVE The purpose of this study is to explore whether entirely asynchronous care leads to different patient outcomes in the form of medication-related adverse events when compared to synchronous virtual care METHODS Using 10,000 randomly sampled patient records from a prominent, U.S. based DTC platform, we analyzed rates of patient-reported side effects from commonly prescribed medications and compared these rates across modalities of treatment RESULTS Fully end-to-end asynchronous care resulted in lower but nonsignificant rates of reported drug-related side effects compared to synchronous treatment. CONCLUSIONS In some circumstances, fully asynchronous care may not create unsafe prescribing conditions when compared to synchronous care. More research is needed to evaluate the safety of asynchronous care across a wider set of circumstances and measures.

Medication side effects

BMJ ◽  
2010 ◽  
Vol 341 (sep15 2) ◽  
pp. c4999-c4999
Keyword(s):  
Side Effects ◽  
Medication Side Effects ◽  
Medication Side

scholarly journals Cutaneous Effects of Notch Inhibitor Therapy: A Report of Two Cases

2020 ◽  
Vol 2020 ◽  
pp. 1-4
Author(s):  
Claire J. Wiggins ◽  
Susan Y. Chon
Keyword(s):  
Side Effects ◽  
Notch Signaling ◽  
Hidradenitis Suppurativa ◽  
Disease Pathogenesis ◽  
Cutaneous Side Effects ◽  
Medication Side Effects ◽  
Medication Side ◽  
Notch Pathways ◽  
Inhibitor Treatment

As aberrant Notch signaling has been linked to cancerous growth, Notch inhibitors represent a novel category of targeted oncological therapy. Notch pathways in tumor cells may contribute to proliferation or limit apoptosis and differentiation. Healthy skin differentiation and homeostasis are reliant on normal Notch expression, and disruption of this signaling has been implicated in dermatological conditions such as hidradenitis suppurativa, psoriasis, atopic dermatitis, and lichen planus. Here, we describe two cases of patients with cutaneous side effects from Notch inhibitor treatment for adenoid cyst carcinoma (ACC) and review the role of Notch signaling in skin disease. By illuminating connections between medication side effects and disease pathogenesis, our goal is to increase awareness of the cutaneous side effects of Notch inhibitor treatment.

Sign in / Sign up

Export Citation Format

Share Document